F901318 - A Two Part Study Designed to Evaluate the Single and Multiple Dose Pharmacokinetics of an Immediate Release Tablet Formulation of F901318
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2016
At a glance
- Drugs F 901318 (Primary) ; F 901318
- Indications Aspergillosis
- Focus Pharmacokinetics
- Sponsors F2G
- 25 Nov 2016 Status changed from recruiting to completed.
- 22 Jul 2016 Status changed from not yet recruiting to recruiting.
- 24 Jun 2016 New trial record